Long intergenic non-protein coding RNA 1267 (LINC01267)

Long intergenic non-protein coding RNA 1267 (LINC01267) is a human long intergenic non-coding RNA (lincRNA), meaning it is a transcript longer than 200 nucleotides that does not encode a protein and originates from a genomic region situated between protein-coding genes[1][3][9]. Like other lincRNAs, it is believed to play roles in regulation of gene expression, chromatin remodeling, and potentially RNA stabilization, often acting in a tissue-specific manner[9][5]. LINC01267 does not encode a receptor, enzyme, transporter, or other conventional "therapeutic target" class but may be involved in fine-tuning cellular functions through RNA-mediated regulatory mechanisms characteristic of lincRNAs[5][9]. No direct evidence supports its role as a biomarker, druggable target, or well-defined participant in any major disease (such as cancer) as per current public databases[1][3]. Context and Supporting Details: - LINC01267 is annotated by NCBI and Ensembl with the gene symbol "LINC01267" and described as "long intergenic non-protein coding RNA 1267," without evidence that it encodes a functional protein or acts as a classical therapeutic target[3][1]. - LincRNAs, as a class, are increasingly recognized for their role in gene regulation, including chromatin modification, acting as scaffolds for multiprotein complexes, and cis/trans regulatory functions; however, the functions of most individual lincRNAs, including LINC01267, are still being discovered[5][9]. - There are no drugs or small molecules currently known to target LINC01267, and no well-established use of LINC01267 as a biomarker or target in a clinical therapeutic context[1][3]. If you require information on lincRNAs involved in specific diseases or established as therapeutic targets, other lincRNAs such as MALAT1 or HOTAIR may be of interest, but LINC01267 is currently not among them according to available sources[5][9].

Other names

LINC01267